13F HOLDINGS REPORT
FCPM III SERVICES B.V.
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0000950123-25-008060
Total Value
$369.2M
Positions
12
Other Managers
3
Confidential Omitted
No
Holdings (12)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 5,984,088 | $108.4M | 29.36% |
| 2 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 4,648,025 | $84.2M | 22.80% |
| 3 | DYNE THERAPEUTICS INC | DYN | 4,036,476 | $38.4M | 10.41% |
| 4 | REPLIMUNE GROUP INC | REPL | 3,909,696 | $36.3M | 9.84% |
| 5 | ENGENE HOLDINGS INC | ENGNW | 6,738,362 | $24.5M | 6.64% |
| 6 | BICYCLE THERAPEUTICS PLC | BCYC | 3,452,330 | $24.0M | 6.50% |
| 7 | ASTRIA THERAPEUTICS INC | 04635X102 | 4,107,537 | $23.4M | 6.34% |
| 8 | DYNE THERAPEUTICS INC | DYN | 1,426,370 | $13.6M | 3.68% |
| 9 | ENGENE HOLDINGS INC | ENGNW | 2,894,199 | $10.5M | 2.85% |
| 10 | RAPT THERAPEUTICS INC | 75382E208 | 440,176 | $3.5M | 0.93% |
| 11 | ENGENE HOLDINGS INC | ENGNW | 2,403,072 | $2.0M | 0.53% |
| 12 | ENGENE HOLDINGS INC | ENGNW | 475,076 | $389,562 | 0.11% |